![Cynthia Anderson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cynthia Anderson
Geen lopende functies
Vermogen: 8 065 $ op 31-05-2026
Profiel
Cynthia L.
Anderson formerly worked at Alnylam Pharmaceuticals, Inc., as Chief Accounting Officer from 2019 to 2023 and Vistagen Therapeutics, Inc., as Chief Financial Officer from 2023 to 2025.
Ms. Anderson received her undergraduate degree from the University of Connecticut and graduate degree from The University of Texas at Dallas.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 16-07-2025 | 12.801 ( 0,03% ) | 8 065 $ | 31-05-2026 |
Eerdere bekende functies van Cynthia Anderson
| Bedrijven | Functie | Einde |
|---|---|---|
| VISTAGEN THERAPEUTICS, INC. | Financieel Directeur/CFO | 15-09-2025 |
| ALNYLAM PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01-01-2023 |
Opleiding van Cynthia Anderson
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
15
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
University of Connecticut
 University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas at Dallas
 The University of Texas at Dallas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
VistaGen Therapeutics, Inc.
 VistaGen Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops central nervous system therapies | Health Technology |
